Cargando…
Identification of diagnostic biomarkers and therapeutic targets in peripheral immune landscape from coronary artery disease
BACKGROUND: Peripheral biomarkers are increasingly vital non-invasive methods for monitoring coronary artery disease (CAD) progression. Their superiority in early detection, prognosis evaluation and classified diagnosis is becoming irreplaceable. Nevertheless, they are still less explored. This stud...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444127/ https://www.ncbi.nlm.nih.gov/pubmed/36064568 http://dx.doi.org/10.1186/s12967-022-03614-1 |
_version_ | 1784783147692457984 |
---|---|
author | Feng, Xiaoteng Zhang, Yifan Du, Min Li, Sijin Ding, Jie Wang, Jiarou Wang, Yiru Liu, Ping |
author_facet | Feng, Xiaoteng Zhang, Yifan Du, Min Li, Sijin Ding, Jie Wang, Jiarou Wang, Yiru Liu, Ping |
author_sort | Feng, Xiaoteng |
collection | PubMed |
description | BACKGROUND: Peripheral biomarkers are increasingly vital non-invasive methods for monitoring coronary artery disease (CAD) progression. Their superiority in early detection, prognosis evaluation and classified diagnosis is becoming irreplaceable. Nevertheless, they are still less explored. This study aimed to determine and validate the diagnostic and therapeutic values of differentially expressed immune-related genes (DE-IRGs) in CAD. METHODS: We downloaded clinical information and RNA sequence data from the GEO database. We used R software, GO, KEGG and Cytoscape to analyze and visualize the data. A LASSO method was conducted to identify key genes for diagnostic model construction. The ssGSEA analysis was used to investigate the differential immune cell infiltration. Besides, we constructed CAD mouse model (low-density lipoprotein receptor deficient mice with high fat diet) to discover the correlation between the screened genes and severe CAD progress. We further uncovered the role of IL13RA1 might play in atherosclerosis. RESULTS: A total of 762 differential genes were identified between the peripheral blood of 218 controls and 199 CAD patients, which were significantly associated with infection, immune response and neural activity. 58 DE-IRGs were obtained by overlapping the differentially expressed genes(DEGs) and immune-related genes downloaded from ImmpDb database. Through LASSO regression, CCR9, CER1, CSF2, IL13RA1, INSL5, MBL2, MMP9, MSR1, NTS, TNFRSF19, CXCL2, HTR3C, IL1A, and NR4A2 were distinguished as peripheral biomarkers of CAD with eligible diagnostic capabilities in the training set (AUC = 0.968) and test set (AUC = 0.859). The ssGSEA analysis showed that the peripheral immune cells had characteristic distribution in CAD and also close relationship with specific DE-IRGs. RT-qPCR test showed that CCR9, CSF2, IL13RA1, and NTS had a significant correlation with LDLR(−/−) mice. IL13RA1 knocked down in RAW264.7 cell lines decreased SCARB1 and ox-LDL-stimulated CD36 mRNA expression, TGF-β, VEGF-C and α-SMA protein levels and increased the production of IL-6, with downregulation of JAK1/STAT3 signal pathway. CONCLUSIONS: We constructed a diagnostic model of advanced-stage CAD based on the screened 14 DE-IRGs. We verified 4 genes of them to have a strong correlation with CAD, and IL13RA1 might participate in the inflammation, fibrosis, and cholesterol efflux process of atherosclerosis by regulating JAK1/STAT3 pathway. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12967-022-03614-1. |
format | Online Article Text |
id | pubmed-9444127 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-94441272022-09-06 Identification of diagnostic biomarkers and therapeutic targets in peripheral immune landscape from coronary artery disease Feng, Xiaoteng Zhang, Yifan Du, Min Li, Sijin Ding, Jie Wang, Jiarou Wang, Yiru Liu, Ping J Transl Med Research BACKGROUND: Peripheral biomarkers are increasingly vital non-invasive methods for monitoring coronary artery disease (CAD) progression. Their superiority in early detection, prognosis evaluation and classified diagnosis is becoming irreplaceable. Nevertheless, they are still less explored. This study aimed to determine and validate the diagnostic and therapeutic values of differentially expressed immune-related genes (DE-IRGs) in CAD. METHODS: We downloaded clinical information and RNA sequence data from the GEO database. We used R software, GO, KEGG and Cytoscape to analyze and visualize the data. A LASSO method was conducted to identify key genes for diagnostic model construction. The ssGSEA analysis was used to investigate the differential immune cell infiltration. Besides, we constructed CAD mouse model (low-density lipoprotein receptor deficient mice with high fat diet) to discover the correlation between the screened genes and severe CAD progress. We further uncovered the role of IL13RA1 might play in atherosclerosis. RESULTS: A total of 762 differential genes were identified between the peripheral blood of 218 controls and 199 CAD patients, which were significantly associated with infection, immune response and neural activity. 58 DE-IRGs were obtained by overlapping the differentially expressed genes(DEGs) and immune-related genes downloaded from ImmpDb database. Through LASSO regression, CCR9, CER1, CSF2, IL13RA1, INSL5, MBL2, MMP9, MSR1, NTS, TNFRSF19, CXCL2, HTR3C, IL1A, and NR4A2 were distinguished as peripheral biomarkers of CAD with eligible diagnostic capabilities in the training set (AUC = 0.968) and test set (AUC = 0.859). The ssGSEA analysis showed that the peripheral immune cells had characteristic distribution in CAD and also close relationship with specific DE-IRGs. RT-qPCR test showed that CCR9, CSF2, IL13RA1, and NTS had a significant correlation with LDLR(−/−) mice. IL13RA1 knocked down in RAW264.7 cell lines decreased SCARB1 and ox-LDL-stimulated CD36 mRNA expression, TGF-β, VEGF-C and α-SMA protein levels and increased the production of IL-6, with downregulation of JAK1/STAT3 signal pathway. CONCLUSIONS: We constructed a diagnostic model of advanced-stage CAD based on the screened 14 DE-IRGs. We verified 4 genes of them to have a strong correlation with CAD, and IL13RA1 might participate in the inflammation, fibrosis, and cholesterol efflux process of atherosclerosis by regulating JAK1/STAT3 pathway. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12967-022-03614-1. BioMed Central 2022-09-05 /pmc/articles/PMC9444127/ /pubmed/36064568 http://dx.doi.org/10.1186/s12967-022-03614-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Feng, Xiaoteng Zhang, Yifan Du, Min Li, Sijin Ding, Jie Wang, Jiarou Wang, Yiru Liu, Ping Identification of diagnostic biomarkers and therapeutic targets in peripheral immune landscape from coronary artery disease |
title | Identification of diagnostic biomarkers and therapeutic targets in peripheral immune landscape from coronary artery disease |
title_full | Identification of diagnostic biomarkers and therapeutic targets in peripheral immune landscape from coronary artery disease |
title_fullStr | Identification of diagnostic biomarkers and therapeutic targets in peripheral immune landscape from coronary artery disease |
title_full_unstemmed | Identification of diagnostic biomarkers and therapeutic targets in peripheral immune landscape from coronary artery disease |
title_short | Identification of diagnostic biomarkers and therapeutic targets in peripheral immune landscape from coronary artery disease |
title_sort | identification of diagnostic biomarkers and therapeutic targets in peripheral immune landscape from coronary artery disease |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444127/ https://www.ncbi.nlm.nih.gov/pubmed/36064568 http://dx.doi.org/10.1186/s12967-022-03614-1 |
work_keys_str_mv | AT fengxiaoteng identificationofdiagnosticbiomarkersandtherapeutictargetsinperipheralimmunelandscapefromcoronaryarterydisease AT zhangyifan identificationofdiagnosticbiomarkersandtherapeutictargetsinperipheralimmunelandscapefromcoronaryarterydisease AT dumin identificationofdiagnosticbiomarkersandtherapeutictargetsinperipheralimmunelandscapefromcoronaryarterydisease AT lisijin identificationofdiagnosticbiomarkersandtherapeutictargetsinperipheralimmunelandscapefromcoronaryarterydisease AT dingjie identificationofdiagnosticbiomarkersandtherapeutictargetsinperipheralimmunelandscapefromcoronaryarterydisease AT wangjiarou identificationofdiagnosticbiomarkersandtherapeutictargetsinperipheralimmunelandscapefromcoronaryarterydisease AT wangyiru identificationofdiagnosticbiomarkersandtherapeutictargetsinperipheralimmunelandscapefromcoronaryarterydisease AT liuping identificationofdiagnosticbiomarkersandtherapeutictargetsinperipheralimmunelandscapefromcoronaryarterydisease |